Caroline Nebhan, MD, PhD, discusses the efficacy of checkpoint inhibitors in older patients with cancer.
Caroline Nebhan, MD, PhD
Advertisement
Articles by Caroline Nebhan, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer
2
Brachytherapy and Minimally Invasive Surgical Techniques Signal the Future of Brain Cancer Management
3
TP53 Co-Mutations and Prognosis in EGFR-Mutated NSCLC
4
Selecting Frontline Therapy for High-Risk EGFR-Mutated NSCLC
5